These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36999380)

  • 1. Truth and lies about the use of old drugs against COVID-19: have we learned the lesson?
    Iorio C; Manfroni G
    Future Med Chem; 2023 Mar; 15(5):399-403. PubMed ID: 36999380
    [No Abstract]   [Full Text] [Related]  

  • 2. SARS-CoV-2 Antiviral Therapy.
    Tao K; Tzou PL; Nouhin J; Bonilla H; Jagannathan P; Shafer RW
    Clin Microbiol Rev; 2021 Dec; 34(4):e0010921. PubMed ID: 34319150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trials with antiviral drugs against COVID-19: some progress and many shattered hopes.
    Brüssow H
    Environ Microbiol; 2021 Nov; 23(11):6364-6376. PubMed ID: 34519154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-purposed antiviral drugs without a purpose in COVID-19: a valuable lesson for clinicians.
    Liuzzo G; Patrono C
    Eur Heart J; 2021 Mar; 42(9):882-883. PubMed ID: 33569601
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets.
    Park SJ; Yu KM; Kim YI; Kim SM; Kim EH; Kim SG; Kim EJ; Casel MAB; Rollon R; Jang SG; Lee MH; Chang JH; Song MS; Jeong HW; Choi Y; Chen W; Shin WJ; Jung JU; Choi YK
    mBio; 2020 May; 11(3):. PubMed ID: 32444382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral Lipid Nanocarrier Loaded with Remdesivir Effective Against SARS-CoV-2 in vitro Model.
    Jeon WJ; Lee HK; Na YG; Jung M; Han SC; Hwang JH; Jung E; Hwang D; Shin JS; Cho CW
    Int J Nanomedicine; 2023; 18():1561-1575. PubMed ID: 37007987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Virology of SARS-CoV-2 and Related Coronaviruses.
    Kung YA; Lee KM; Chiang HJ; Huang SY; Wu CJ; Shih SR
    Microbiol Mol Biol Rev; 2022 Jun; 86(2):e0002621. PubMed ID: 35343760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Chronicle of COVID-19 and Possible Strategies to Curb the Pandemic.
    Kumar R; Harilal S; Al-Sehemi AG; Mathew GE; Carradori S; Mathew B
    Curr Med Chem; 2021; 28(15):2852-2886. PubMed ID: 32614740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotechnology and COVID-19 Convergence: Toward New Planetary Health Interventions Against the Pandemic.
    Sahoo P; Dey J; Mahapatra SR; Ghosh A; Jaiswal A; Padhi S; Prabhuswamimath SC; Misra N; Suar M
    OMICS; 2022 Sep; 26(9):473-488. PubMed ID: 36040392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of glutamine 189 flexibility in SARS-CoV-2 main protease: Lesson learned from in silico virtual screening of ChEMBL database and molecular dynamics.
    Said MA; Albohy A; Abdelrahman MA; Ibrahim HS
    Eur J Pharm Sci; 2021 May; 160():105744. PubMed ID: 33540040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of the novel coronavirus SARS-CoV-2 and potential anti-COVID19 pharmacological targets since the outbreak of the pandemic.
    Vlachakis D; Papakonstantinou E; Mitsis T; Pierouli K; Diakou I; Chrousos G; Bacopoulou F
    Food Chem Toxicol; 2020 Dec; 146():111805. PubMed ID: 33038452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovering small-molecule therapeutics against SARS-CoV-2.
    Tiwari V; Beer JC; Sankaranarayanan NV; Swanson-Mungerson M; Desai UR
    Drug Discov Today; 2020 Aug; 25(8):1535-1544. PubMed ID: 32574699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress on COVID-19 Chemotherapeutics Discovery and Novel Technology.
    Zhou Y; Wang H; Yang L; Wang Q
    Molecules; 2022 Nov; 27(23):. PubMed ID: 36500347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 virus infection: Targets and antiviral pharmacological strategies.
    Campos DMO; Fulco UL; de Oliveira CBS; Oliveira JIN
    J Evid Based Med; 2020 Nov; 13(4):255-260. PubMed ID: 33058394
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacological Strategies for COVID-19 - A Review of the Most Promising Repurposed Antiviral Drugs.
    Chopra D; Boparai JK; Bhandari B; Srivastava A; Gupta R
    Infect Disord Drug Targets; 2021; 21(7):e160921189260. PubMed ID: 33342420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies.
    Kumari M; Lu RM; Li MC; Huang JL; Hsu FF; Ko SH; Ke FY; Su SC; Liang KH; Yuan JP; Chiang HL; Sun CP; Lee IJ; Li WS; Hsieh HP; Tao MH; Wu HC
    J Biomed Sci; 2022 Sep; 29(1):68. PubMed ID: 36096815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological Effects of SARS-CoV-2 and Neurotoxicity of Antiviral Drugs Against COVID-19.
    Ünlü B; Simsek R; Köse SBE; Yirün A; Erkekoglu P
    Mini Rev Med Chem; 2022; 22(2):213-231. PubMed ID: 34191697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Agents Against COVID-19 with Clinical Evidence.
    Tian C; Xiang M
    Curr Pharm Des; 2021; 27(13):1608-1617. PubMed ID: 33459226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in understanding COVID-19: insights from the omics approach.
    Lin B; Liu J; Liu Y; Qin X
    Crit Rev Clin Lab Sci; 2021 Jun; 58(4):242-252. PubMed ID: 33375876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plant lectins as prospective antiviral biomolecules in the search for COVID-19 eradication strategies.
    Ahmed MN; Jahan R; Nissapatorn V; Wilairatana P; Rahmatullah M
    Biomed Pharmacother; 2022 Feb; 146():112507. PubMed ID: 34891122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.